Biolegend, 374004, Alexa Fluor® 594 anti-human CD309 (VEGFR2) Antibody
100microg
Catalog Number: 374004
Send an RFQ.
Category
| Verified Reactivity | Human |
|---|---|
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Immunogen | Recombinant Human VEGFR2-Fc Chimera |
| Formulation | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide. |
| Preparation | The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 594 under optimal conditions. |
| Concentration | 0.5 mg/ml |
| Storage & Handling | The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze. |
| Application | IHC-P - Quality tested |
| Recommended Usage | Each lot of this antibody is quality control tested by immunohistochemistry. For immunohistochemistry, a concentration range of 5-10 μg/ml is suggested. It is recommended that the reagent be titrated for optimal performance for each application. * Alexa Fluor® 594 has an excitation maximum of 590 nm, and a maximum emission of 617 nm. Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.View full statement regarding label licenses |
| RRID | AB_2716157 (BioLegend Cat. No. 374003) |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Structure |
|---|
| Type I transmembrane glycoprotein, type III tyrosine kinase receptor, CSF-1/PDGF receptor family |
| Distribution | Endothelial cells, embryonic tissues |
|---|
| Function | VEGFR2 regulates angiogenesis as well as vascular development and permeability |
|---|
| Interaction | VEGF-A, SHC2, NPR1, NCK1 |
|---|
| Ligand/Receptor | VEGF-A, VEGF-C, and VEGF-D splice isoforms |
|---|
| Cell Type | Endothelial cells |
|---|
| Biology Area | Angiogenesis, Cell Biology, Immunology |
|---|
| Molecular Family | CD Molecules, Cytokine/Chemokine Receptors |
|---|
| Antigen References | 1. DiSalvo J, et al. 1995. J. Biol. Chem. 270:7717. 2. McColl BK, et al. 2003. J. Exp. Med. 198:863. 3. Albuquerque RJ, et al. 2009. Nat. Med. 15:1023. 4. Guangqi E, et al. 2012. J. Biol. Chem. 287:3029. 5. Koch S, and Claesson-Welsh 2012. Cold Spring Harb Perspect Med 2:a006502. 6. Munaut C, et al. 2012. Plos One 7:e33475. 7. Wehland M, et al. 2013. Int. J. Mol. Sci. 14:9338. |
|---|
| Gene ID | 3791 |
|---|
| UniProt | View information about CD309 on UniProt.org |
|---|
| Clone | A16085I |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | VEGFR2, KDR |
|---|
| Isotype | Mouse IgG2b, κ |
|---|